Phase 2 clinical trials have reported efimosfermin to be beneficial in MASH resolution and fibrosis regression in patients with MASH and F2/F3 fibrosis
ORs and 95% CIs were computed for these binary variables
Firstly, through a systematic review and network meta-analysis, researchers have assessed the effects of GLP-1R agonists on neuroinflammation and reported that, compared with placebo, GLP-1R agonists significantly reduce the levels of neuroinflammatory markers, such as TNF- and interleukin-1 (Urkon et al., 2025
His background includes medical training, internal medicine residency, holistic and integrative medicine experience, and a long-standing focus on individualized patient care
GLP-1 Targeting Built via Contextual Signals GLP-1 (Glucagon Like Peptide 1) medications are a class of drugs that mimic the GLP-1 hormone to lower blood sugar and reduce appetite